ArticleBioinformatics (Oxford, England)2024
A hypercubic Mk model framework for capturing reversibility in disease, cancer, and evolutionary accumulation modelling.
Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Summarizing Evolutionary Trajectories from Phylogenetic Character Maps of Discrete Traits.bioRxiv : the preprint server for biology · 2026Article
- Evolutionary inference reveals global natural histories and predicted pathways of antimicrobial resistance in Klebsiella pneumoniae.PLoS biology · 2026Article
- Review
- HyperTraPS-CT: Inference and prediction for accumulation pathways with flexible data and model structures.PLoS computational biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
motivationAccumulation models, where a system progressively acquires binary features over time, are common in the study of cancer progression, evolutionary biology, and other fields. Many approaches have been developed to infer the accumulation pathways by which features (e.g. mutations) are acquired over time. However, most of these approaches do not support reversibility: the loss of a feature once it has been acquired (e.g. the clearing of a mutation from a tumor or population).
resultsHere, we demonstrate how the well-established Mk model from evolutionary biology, embedded on a hypercubic transition graph, can be used to infer the dynamics of accumulation processes, including the possibility of reversible transitions, from data which may be uncertain and cross-sectional, longitudinal, or phylogenetically/phylogenomically embedded. Positive and negative interactions between arbitrary sets of features (not limited to pairwise interactions) are supported. We demonstrate this approach with synthetic datasets and real data on bacterial drug resistance and cancer progression. While this implementation is limited in the number of features that can be considered, we discuss how this limitation may be relaxed to deal with larger systems. AVAILABILITY AND IMPLEMENTATION: The code implementing this setup in R is freely available at https://github.com/StochasticBiology/hypermk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.